Breaking News
4 hours ago
Mrudula Kulkarni
CMS delays LCD, protecting Medicare patient access to wound care skin substitutes until 2026.
Priyanka Patil
FDA supports Phase 3 design for darovasertib in uveal melanoma with vision-based endpoints.
Priyanka Patil
Roche's Columvi® combo wins EU nod for earlier DLBCL use, boosting survival in hard-to-treat cases.
Simantini Singh Deo
Eyestem's Eyecyte-RPE™ shows vision gains in dry AMD Phase 1 trial.
Simantini Singh Deo